Monoclonal Antibodies
Anti-Olig2 Rabbit Monoclonal Antibody for WB, ELISA - Q13516
Item Number : CM0010100
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Mouse, Rat
- Protein Weight
- 32kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | Olig2 Rabbit mAb |
| Remarks/Alias | BHLHB1; OLIGO2; RACK17; PRKCBP2; bHLHe19; Olig2 |
| Species | Human |
| GeneID (Human) | 10215 |
| GeneID | 10215 |
| Immunogen | Synthetic Peptide|A synthetic peptide corresponding to a sequence within amino acids 200-300 of human Olig2 (Q13516). |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Mouse, Rat |
| SWISS | Q13516 |
| Protein Weight | 32kDa |
| Shipping | Ice bag |
Biological Background: Olig2 Function and Localization
- Olig2 is a class B basic helix-loop-helix (bHLH) transcription factor, also designated BHLHB1, bHLHe19, PRKCBP2, or RACK17, that binds DNA to regulate gene expression.
- It is essential for oligodendrocyte and motor neuron specification in the spinal cord and for somatic motor neuron development in the hindbrain.
- Olig2 cooperates with ZNF488 to drive oligodendrocyte differentiation and works alongside OLIG1 to establish the pMN progenitor domain of the embryonic neural tube.
- During cortical development, it controls progenitor fate decisions in gliogenesis and contributes to gliomagenesis; it is classified as a proto-oncogene subject to chromosomal rearrangements.
- The protein acts as a transcriptional repressor of GSX2 by binding and silencing multiple conserved enhancer elements, thereby suppressing olfactory bulb interneuron intermediate progenitor generation.
- It is found in both the nucleus and the cytoplasm, consistent with its DNA-binding role and potential shuttling between compartments.
- Olig2 is predominantly expressed in the brain, notably in oligodendrocytes; it is highly expressed in oligodendrogliomas, with variable levels in astrocytomas and glioblastomas.
- Key post-translational modifications include ubiquitin-like conjugation, and the protein has been identified in proteomic screens.
Experimental Guidance and Technical Tips
- The immunogen is a synthetic peptide from the internal region (aa 200–300) of human Olig2; the antibody is expected to recognize the full-length protein at ~32 kDa in Western blotting.
- For WB, use lysates from human, mouse, or rat brain tissue or Olig2-expressing cell lines (e.g., oligodendroglioma) and validate with appropriate loading controls.
- In ELISA, consider using the immunogen peptide or recombinant Olig2 protein as a standard and optimize coating conditions to ensure specificity.
- Since the antibody cross-reacts with mouse and rat, it is suitable for comparative and cross-species studies; verify reactivity in your specific experimental system.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio offers this anti-Olig2 monoclonal antibody as part of a comprehensive portfolio for oligodendrocyte differentiation and gliomagenesis research. We support diagnostic manufacturers and laboratories with validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and custom raw-material sourcing. Our one-stop platform accelerates your transition from concept to clinic by providing dependable IVD components and technical expertise.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!
Related Articles
qPCR Primer Design: The Small Decisions That Determine Assay Reliability
A practical guide to qPCR primer design, from amplicon length and 3' stability to validation for efficient, reproducible diagnostics.
When a Surface Becomes a Sensor: Choosing Between QCM, SAW, and Six Classes of Quality Detection
Explore six sensor families, how QCM and SAW convert molecular binding into frequency shifts, and why surface chemistry determines diagnostic reliability.
The Silent Well: How No Template Controls Protect Molecular Diagnostic Integrity
A practical guide to No Template Controls: how unexpected qPCR signals reveal contamination, reagent impurities, artifacts, and broken workflow controls.
Why Minor Groove Binders Turn Short Hydrolysis Probes into Precision Diagnostic Tools
MGB chemistry improves probe stability, SNP discrimination, signal-to-noise ratio, and low-copy detection in demanding molecular assays.
From Molecular Binding to Manufacturing Discipline: How Reliable ELISA Kits Are Engineered
Explore the four operational mechanisms that govern ELISA kit performance, from passive coating and washing to signal generation and scalable IVD manufacturing.
Engineering the Weakest Link: Recombinant Antibodies for Reliable Multi-Analyte Biosensors
Learn how engineered recombinant antibodies improve multi-analyte biosensors through uniform recognition, oriented surfaces, avidity, and wider dynamic range.
qPCR Efficiency: The Mathematical Foundation of Reliable Molecular Diagnostics
Learn how qPCR efficiency is calculated, why the 90–100% range matters, and how it protects diagnostic accuracy, sensitivity, and compliance.
Competitive ELISA vs. GC/MS: Building a Faster, Defensible Strategy for Trace Detection
Learn how competitive ELISA compares with GC/MS for trace detection and how to validate immunoassay kits for reliable laboratory screening.
When Fluorescence Becomes Evidence: Engineering a Competitive ELISA for Trace Molecule Detection
Learn how procedural discipline, blank correction, substrate selection, and reader configuration turn fluorometric ELISA sensitivity into reliable trace detection.
Why Open Chemistry and Flexible Reaction Volumes Define Better Diagnostic PCR Systems
Learn how open chemistry compatibility and flexible reaction volumes improve PCR assay control, sensitivity, cost, scalability, and supply independence.
Choosing the Right High-Throughput Toxicology Platform: Cell-Based Bioassays Versus ELISA
Compare cell-based bioassays and ELISA for toxicology screening, from biological relevance and throughput to validation and technical support.
Lab-on-a-Chip Diagnostics: Why Miniaturization Succeeds Only When Chemistry, Materials, and Workflow Align
Explore how lab-on-a-chip platforms accelerate diagnostics and why raw materials, surface chemistry, assay integration, and usability determine success.